DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Regulatory Affairs in China" conference has been added to Research and Markets' offering.
This seminar will provide a detailed overview of the key areas of pharmaceutical regulatory affairs in China, Hong Kong, Macau and Taiwan and will cover:
All important aspects of gaining and maintaining a successful Marketing Authorisation in the region
- Drug regulatory systems
- An overview of import and local manufacture registration
- Clinical product development including CMC regulatory requirements
- An interpretation of practical aspects
- Recent developments
- The opportunity to exchange experiences with other delegates
Benefits of attending this meeting:
- Gain an overview of the regulatory procedures in the region
- Comply with CMC regulatory requirements
- Understand requirements for import and local manufacture registration
- Discuss product registration strategies
- Assess the impact of recent regulatory developments
Why you should attend
This seminar will provide a detailed overview of how to gain and maintain a successful pharmaceutical marketing authorisation in PR China, including Hong Kong, Macau and Taiwan.
The two day course will cover:
- All important aspects of gaining and maintaining a successful Marketing Authorisation in the region
- Drug regulatory systems
- An overview of import and local manufacture registration
- Clinical product development including CMC regulatory requirements
- An interpretation of practical aspects
- Recent developments
- The opportunity to exchange experiences with other delegates
For more information about this conference visit https://www.researchandmarkets.com/research/4xrfpr/pharmaceutical